Richard D Feinman
Overview
Explore the profile of Richard D Feinman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1507
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krzesaj P, Adler V, Feinman R, Miller A, Silberstein M, Yazdi E, et al.
Ann Clin Lab Sci
. 2024 May;
54(2):137-148.
PMID: 38802154
Objective: We have previously shown that the anti-cancer peptide PNC-27 kills cancer cells by co-localizing with membrane-expressed HDM-2, resulting in transmembrane pore formation causing extrusion of intracellular contents. We have...
2.
Miller A, Diaz D, Lin B, Krzesaj P, Ustoyev S, Shim A, et al.
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760956
The ketone bodies, sodium and lithium salts of acetoacetate (AcAc) and sodium 3-hydroxybutyrate (3-HB; commonly called beta-hydroxybutyrate) have been found to inhibit the proliferation of cancer cells. Previous studies have...
3.
Feinman R, Lechner K, Fine E, Elliott J, Thompson-Starkey M, OHearn L, et al.
Lancet Public Health
. 2022 Jul;
7(7):e581.
PMID: 35779540
No abstract available.
4.
Zou Y, Fineberg S, Pearlman A, Feinman R, Fine E
PLoS One
. 2020 Dec;
15(12):e0233662.
PMID: 33270630
Background: The effects of diet in cancer, in general, and breast cancer in particular, are not well understood. Insulin inhibition in ketogenic, high fat diets, modulate downstream signaling molecules and...
5.
Feinman R
Curr Opin Endocrinol Diabetes Obes
. 2020 Aug;
27(5):261-268.
PMID: 32796164
Purpose Of Review: To summarize the underlying biochemical basis for low-carbohydrate and ketogenic diets (LC/KD) and provide mechanisms to account for demonstrated effectiveness. Recent Findings: LC/KD continue to have success,...
6.
Feinman R, Pogozelski W, Astrup A, Bernstein R, Fine E, Westman E, et al.
Nutrition
. 2019 Apr;
62:213.
PMID: 30935711
No abstract available.
7.
Klement R, Feinman R, Gross E, Champ C, DAgostino D, Fine E, et al.
Med Oncol
. 2017 Apr;
34(6):108.
PMID: 28452037
No abstract available.
8.
Feinman R, Pogozelski W, Astrup A, Bernstein R, Fine E, Westman E, et al.
Nutrition
. 2014 Oct;
31(1):1-13.
PMID: 25287761
The inability of current recommendations to control the epidemic of diabetes, the specific failure of the prevailing low-fat diets to improve obesity, cardiovascular risk, or general health and the persistent...
9.
Feinman R, Fine E
Nutr Metab (Lond)
. 2013 Jul;
10(1):45.
PMID: 23815799
Whether dietary fructose (as sucrose or high fructose corn syrup) has unique effects separate from its role as carbohydrate, or, in fact, whether it can be considered inherently harmful, even...
10.
Fine E, Segal-Isaacson C, Feinman R, Herszkopf S, Romano M, Tomuta N, et al.
Nutrition
. 2012 Jul;
28(10):1028-35.
PMID: 22840388
Objective: Most aggressive cancers demonstrate a positive positron emission tomographic (PET) result using ¹⁸F-2-fluoro-2-deoxyglucose (FDG), reflecting a glycolytic phenotype. Inhibiting insulin secretion provides a method, consistent with published mechanisms, for...